A carregar...
WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages
BACKGROUND: Although the standard treatment for the patients with recurrent and metastatic prostate cancer (CaP) is androgen deprivation therapy, castration-resistant prostate cancer (CRPC) eventually emerges. Our previous report indicated that bone morphogenetic protein 6 (BMP6) induced CRPC via tu...
Na minha lista:
| Publicado no: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5846063/ https://ncbi.nlm.nih.gov/pubmed/29381686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.451 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|